Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Khirurgiia|November 27, 2023
[Integral scales in assessing the risk of postoperative morbidity and mortality]Z A Bagateliya, D N Grekov, A G Komarova, et al.
Klinicheskaia Laboratornaia Diagnostika|February 22, 2022
Soluble forms of PD-1/PD-L immune checkpoint receptor and ligand in blood serum of breast cancer patients: association with clinical pathologic factors and molecular type of the tumorElena Sergeyevna Gershtein, E A Korotkova, I K Vorotnikov, et al.
Bulletin of Experimental Biology and Medicine|September 29, 2023
Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1E S Gershtein, A S Mochalova, E A Korotkova, et al.
Klinicheskaia Laboratornaia Diagnostika|April 1, 2021
Prognostic significance of soluble forms of immune checkpoint PD-1/PDL1 receptor and ligand in blood plasma of gastric cancer patientsNikolay Evgenievich Kushlinskii, E S Gershtein, V L Chang, et al.
Bulletin of Experimental Biology and Medicine|December 12, 2023
Soluble B7-H3 in Colorectal CancerO V Kovaleva, A N Gratchev, N Yu Sokolov, et al.
Khirurgiia|December 19, 2025
[Correlation of somatic status and postoperative complications in comorbid patients with locally advanced colon cancer]V M Kulushev, A V Shabunin, Z A Bagatelia, et al.
Doklady. Biochemistry and Biophysics|April 25, 2021
Immunosuppression Factors PD-1, PD-L1, and IDO1 and Colorectal CancerO V Kovaleva, M A Rashidova, A N Gratchev, et al.
Klinicheskaia Laboratornaia Diagnostika|March 18, 2021
Soluble forms of immune checkpoints in ovarian cancerO V Kovaleva, T P Belova, D N Kushlinsky, et al.
Bulletin of Experimental Biology and Medicine|November 24, 2020
Key Immune Checkpoint PD-1/PD-L1 Signaling Pathway Components in the Blood Serum from Patients with Bone TumorsN E Kushlinskii, A A Alferov, Yu S Timofeev, et al.
Klinicheskaia Laboratornaia Diagnostika|December 10, 2020
Comparative analysis of the levels of soluble forms of receptor and ligand of the immunity control point PD-1/PD-L1 in the blood serum of patients with typical bone osteosarcoma and chondrosarcomaNikolay Evgenievich Kushlinskii, A A Alferov, I V Boulytcheva, et al.
Pageof 1